CoChat

The crosstalk between HIFs and mitochondrial dysfunctions in cancer development

Open access
Bao, Xingting, Zhang, Jinhua, Huang, Guomin, Yan, Junfang, Xu, Caipeng, Dou, Zhihui, Sun, Chao, Zhang, Hong · 2021 · Cell Death & Disease

The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.

Abstract

Mitochondria are essential cellular organelles that are involved in regulating cellular energy, metabolism, survival, and proliferation. To some extent, cancer is a genetic and metabolic disease that is closely associated with mitochondrial dysfunction. Hypoxia-inducible factors (HIFs), which are major molecules that respond to hypoxia, play important roles in cancer development by participating in multiple processes, such as metabolism, proliferation, and angiogenesis. The Warburg phenomenon reflects a pseudo-hypoxic state that activates HIF-1α. In addition, a product of the Warburg effect, lactate, also induces HIF-1α. However, Warburg proposed that aerobic glycolysis occurs due to a defect in mitochondria. Moreover, both HIFs and mitochondrial dysfunction can lead to complex reprogramming of energy metabolism, including reduced mitochondrial oxidative metabolism, increased glucose uptake, and enhanced anaerobic glycolysis. Thus, there may be a connection between HIFs and mitochondrial dysfunction. In this review, we systematically discuss the crosstalk between HIFs and mitochondrial dysfunctions in cancer development. Above all, the stability and activity of HIFs are closely influenced by mitochondrial dysfunction related to tricarboxylic acid cycle, electron transport chain components, mitochondrial respiration, and mitochondrial-related proteins. Furthermore, activation of HIFs can lead to mitochondrial dysfunction by affecting multiple mitochondrial functions, including mitochondrial oxidative capacity, biogenesis, apoptosis, fission, and autophagy. In general, the regulation of tumorigenesis and development by HIFs and mitochondrial dysfunction are part of an extensive and cooperative network.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41419-021-03505-1

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schema of regulation of HIF-α degradation and transcriptional activity. Under conditions of normoxia, HIF-1α and HIF-2α are continuously degraded through the key oxygen sensor PHD1–3, especially PHD2 which enables HIF-α to bind to the pVHL. FIH also inhibits HIF-α by binding to HIF-α and impeding thecombination of HIF-α to the transcriptional coactivators CBP and p300. Under hypoxic conditions, the hydroxylation of HIFα is restrained, leading to stabilization of HIF-α. Next, HIF-α dimerizes with HIF-1β to comprise a transcriptional activation complex, which binds to HRE and stimulates the transactivation of target genes.
Fig. 1 Schema of regulation of HIF-α degradation and transcriptional activity. Under conditions of normoxia, HIF-1α and HIF-2α are continuously degraded through the key oxygen sensor PHD1–3, especially PHD2 which enables HIF-α to bind to the pVHL. FIH also inhibits HIF-α by binding to HIF-α and impeding thecombination of HIF-α to the transcriptional coactivators CBP and p300. Under hypoxic conditions, the hydroxylation of HIFα is restrained, leading to stabilization of HIF-α. Next, HIF-α dimerizes with HIF-1β to comprise a transcriptional activation complex, which binds to HRE and stimulates the transactivation of target genes.CC BY · PubMed Central
Fig. 2 Role of HIFs in cancer progression. HIFs have a wide range of target genes which function to manage different types of signaling pathways in cancer. As an example, HIFs modulate cellular metabolic reprogramming, cell proliferation and survival, angiogenesis, apoptosis, and EMT.
Fig. 2 Role of HIFs in cancer progression. HIFs have a wide range of target genes which function to manage different types of signaling pathways in cancer. As an example, HIFs modulate cellular metabolic reprogramming, cell proliferation and survival, angiogenesis, apoptosis, and EMT.CC BY · PubMed Central
Fig. 3 The effect of mitochondrial dysfunction on HIFs. The stability and activity of HIF-α are closely influenced by mitochondrial dysfunction related to the TCA cycle, ETC components, and mitochondrial respiration. First, dysregulation of the TCA cycle affects HIF stability and activity. Mutations of the TCA cycle enzymes, including IDH, SDH, and FH, cause stabilization and accumulation of HIF by inhibiting PHDs. Loss of IDH2 also leads to ROS-dependent stabilization of HIF-1α under normoxic conditions. However, inhibition of MDH2 stimulates HIF-1α degradation in cancer cells. Second, ETC components can have an effect on the stability and activity of HIFs. Mutations of complex I and complex II (also known as SDH) leads to HIF-1α stabilization by increasing ROS and succinate levels, respectively. The mitochondrial complex III can sense hypoxic conditions and produce ROS, which stabilizes the HIF-1α protein. However, deficiency and inhibition of complex I cause decreased HIF-1α stabilization using PHD-mediated degradation. In addition, suppression of mitochondrial respiration impedes stabilization of HIF-1α by reactivating PHD enzymes.
Fig. 3 The effect of mitochondrial dysfunction on HIFs. The stability and activity of HIF-α are closely influenced by mitochondrial dysfunction related to the TCA cycle, ETC components, and mitochondrial respiration. First, dysregulation of the TCA cycle affects HIF stability and activity. Mutations of the TCA cycle enzymes, including IDH, SDH, and FH, cause stabilization and accumulation of HIF by inhibiting PHDs. Loss of IDH2 also leads to ROS-dependent stabilization of HIF-1α under normoxic conditions. However, inhibition of MDH2 stimulates HIF-1α degradation in cancer cells. Second, ETC components can have an effect on the stability and activity of HIFs. Mutations of complex I and complex II (also known as SDH) leads to HIF-1α stabilization by increasing ROS and succinate levels, respectively. The mitochondrial complex III can sense hypoxic conditions and produce ROS, which stabilizes the HIF-1α protein. However, deficiency and inhibition of complex I cause decreased HIF-1α stabilization using PHD-mediated degradation. In addition, suppression of mitochondrial respiration impedes stabilization of HIF-1α by reactivating PHD enzymes.CC BY · PubMed Central
Fig. 4 Function of HIFs on mitochondrial dysfunction. HIFs have an effect on multiple mitochondrial functions, including mitochondrial oxidative capacity, OXPHOS, biogenesis, apoptosis, fission, and autophagy. HIF-1 activation downregulates mitochondrial oxidation by inhibiting ATGL-mediated lipolysis via HIG2, which leads to LD storage and subsequently declines mitochondrial FA oxidation under hypoxic conditions, and by inducing PDK, which inhibits PDH, thereby inhibiting the flow of pyruvate into the TCA cycle. HIF-1 also regulates mitochondrial redox by inducing mitochondrial serine catabolism and the production of NADPH. Furthermore, miR-210, which is upregulated by HIF-1, restrains expression of the Fe–S cluster assembly proteins ISCU-1 and ISCU-2, which further restricts mitochondrial ROS generation and induces a shift of energy metabolism from OXPHOS to glycolysis. HIF-1 stimulates the less active ETC components, including NDUFA4L2, COX4-1, COX4-2, complex I, and complex IV, to delay the electron transfer through the ETC, therefore blocking the accumulation of ROS and reducing ROS-mediated apoptosis. HIF-1α reduces mitochondrial biogenesis by targeting PGC-1α, MXI, and HEY1. Meanwhile, NPAS2 increases the expression of glycolytic genes by transcriptionally upregulating HIF-1α. HIF-1 also regulates apoptosis by promoting the formation of VDAC1-∆C from VDAC1. Mitochondrial fission, which results in the activation of mitochondria-associated apoptosis, is negatively regulated by the HIF/miR-125a/Mfn2 pathways during carcinogenesis. Mitochondrial proteins can also be inhibited by suppression of the mTORC1/p70SK/S6 signaling pathway via action of HIF-1α. HIF-1α also induces BNIP3 to promote mitochondrial autophagy.
Fig. 4 Function of HIFs on mitochondrial dysfunction. HIFs have an effect on multiple mitochondrial functions, including mitochondrial oxidative capacity, OXPHOS, biogenesis, apoptosis, fission, and autophagy. HIF-1 activation downregulates mitochondrial oxidation by inhibiting ATGL-mediated lipolysis via HIG2, which leads to LD storage and subsequently declines mitochondrial FA oxidation under hypoxic conditions, and by inducing PDK, which inhibits PDH, thereby inhibiting the flow of pyruvate into the TCA cycle. HIF-1 also regulates mitochondrial redox by inducing mitochondrial serine catabolism and the production of NADPH. Furthermore, miR-210, which is upregulated by HIF-1, restrains expression of the Fe–S cluster assembly proteins ISCU-1 and ISCU-2, which further restricts mitochondrial ROS generation and induces a shift of energy metabolism from OXPHOS to glycolysis. HIF-1 stimulates the less active ETC components, including NDUFA4L2, COX4-1, COX4-2, complex I, and complex IV, to delay the electron transfer through the ETC, therefore blocking the accumulation of ROS and reducing ROS-mediated apoptosis. HIF-1α reduces mitochondrial biogenesis by targeting PGC-1α, MXI, and HEY1. Meanwhile, NPAS2 increases the expression of glycolytic genes by transcriptionally upregulating HIF-1α. HIF-1 also regulates apoptosis by promoting the formation of VDAC1-∆C from VDAC1. Mitochondrial fission, which results in the activation of mitochondria-associated apoptosis, is negatively regulated by the HIF/miR-125a/Mfn2 pathways during carcinogenesis. Mitochondrial proteins can also be inhibited by suppression of the mTORC1/p70SK/S6 signaling pathway via action of HIF-1α. HIF-1α also induces BNIP3 to promote mitochondrial autophagy.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

3 retracted

Show all 130 references

Research works printed but not linked: 1

  1. Guo, Y. et al. Hypoxiainducible factors in hepatocellular carcinoma (Review). Oncol. Rep. 43, 3–15 (2020).

Cited by

See all 152

Metadata

Authors
Bao, X., Zhang, J., Huang, G., Yan, J., Xu, C., Dou, Z., Sun, C., & Zhang, H.
Affiliations
Chinese Academy of Sciences (CN)
Corresponding author
  • Sun, Chao
  • Zhang, Hong
Venue
Cell Death & Disease
Published
2021-02-26
Volume
12
Issue
2
Pages
215-215
ISSN
2041-4889 (ISSN-L)
OpenAlex
W3132095850
Cited by
152
References
130
Citations by year
2026: 31 · 2025: 38 · 2024: 32 · 2023: 25 · 2022: 21 · 2021: 4
FWCI
2.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Death and Disease (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (2018YFE0205100, U1632270, 11775280, 2020414)
  • Chinese Academy of Sciences (U1632270)
  • University of Chinese Academy of Sciences
  • Youth Innovation Promotion Association (2020414)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
hypoxia-inducible factor, HIF-1α, mitochondrial dysfunction, cancer metabolism, Warburg effect, aerobic glycolysis, tumor hypoxia, TCA cycle, electron transport chain, mitochondrial respiration, mitochondrial biogenesis, mitochondrial fission, mitophagy, apoptosis, carcinogenesis, lactate
MeSH terms
Tumor Hypoxia, Endothelial PAS Domain-Containing Protein 1, Animals, Energy Metabolism, Humans, Mitochondria, Neoplasms, Neovascularization, Pathologic, Repressor Proteins, Signal Transduction, Cell Death, Cell Proliferation, Apoptosis Regulatory Proteins, Aryl Hydrocarbon Receptor Nuclear Translocator, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit, Epithelial-Mesenchymal Transition, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The crosstalk between HIFs and mitochondrial dysfunctions in cancer development. https://app.cochat.ai/papers/10.1038/s41419-021-03505-1
The paper
Bao, X., Zhang, J., Huang, G., Yan, J., Xu, C., Dou, Z., Sun, C., & Zhang, H. (2021). The crosstalk between HIFs and mitochondrial dysfunctions in cancer development. Cell Death & Disease. https://doi.org/10.1038/s41419-021-03505-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.